Tag: Insulin

Out-of-pocket cost of insulin increased from $1,678 to $2,800 per person per year in pre- to post-ACA period for uninsured population

Improved glucose control seen with no increase in hypoglycemia compared with standard insulin therapy

Strong recommendations include use of glucagon preparations that do not need reconstitution, real-time CGM for those receiving multiple daily injections

Lower odds ratios seen for insulin pump use for Hispanic, Black, other race versus White; with lower education, lower household income

Variation seen among subgroups, with rationing in 11.2 percent of those aged 65 years and older and 20.4 percent of younger persons

Equipment issue may allow someone to break in and cause the pump to deliver too much or too little insulin to the patient

Patients receiving BIHAP, using both insulin and glucagon, spent more time in euglycemia, less time in hypoglycemia

Percentage of time in target glucose range increased with open-source AID versus sensor-augmented insulin pump

Intensive glucose control for 24 months did not appear to prevent the decline in residual C-peptide secretion

Daily insulin dose linked to cancer risk in multivariable model, with increasing cancer incidence in low-, medium-, high-dose insulin groups